Table 5.
ATM variants.
patient | consanguineous parents | affected siblings | cDNA change | protein change | variant type | ACMG classification | ATM protein (activity) | reference |
---|---|---|---|---|---|---|---|---|
p1-2family1 | no | sibling with A-T | c.8655dup c.332-?_8850+?del |
p.Val2886Cysfs*10 NA |
truncation full gene deletion |
5 5 |
NA | [29] |
p3-4family2 | yes | 3 siblings: A-T, suspected A-T, and not affected | c.7788G > A homozygous | p.Glu2596Glu | aberrant splicing | 5 | very low (absent) | [16] |
p5-7family3 | no | 2 (p5), 3 (p6), 1 (p7) siblings, none affected | c.3576G > A homozygous | p.Lys1192Lys | aberrant splicing | 5 | NA | [16] |
P8family4 | no | 1 sibling, not affected | c.3673C > T c.8655dup |
p.Gln1225* p.Val2886Cysfs*10 |
truncation truncation |
5 5 |
NA | [29] [29] |
p9family5 | yes | 2 siblings, not affected | c.3576G > A homozygous | p.Lys1192Lys | aberrant splicing | 5 | NA | [16] |
p10family6 | yes | 3 siblings, not affected | c.3576G > A homozygous | p.Lys1192Lys | aberrant splicing | 5 | NA | [16] |
p11family7 | no | 2 siblings, not affected | c.9029T > G c.6095G > A |
p.Leu3010Ter p.Arg2032Lys |
truncation aberrant splicing |
4 5 |
NA | [30] [15] |
p12family8 | no | 1 sibling, not affected | c.487C > T c.3284G > C |
p.Gln163* p.Arg1095Thr |
truncation aberrant splicing |
5 4 |
NA | [30] [30] |
p13family9 | no | 1 sibling, not affected | c.3214G > T c.8147T > C |
p.Glu1072* p.Val2716Ala |
truncation missense |
5 5 |
reduced (normal) | [12] [12] |
p14family10 | no | 4 siblings, 2 with undiagnosed movement disorder | c.6040G > A c.8122G > A |
p.Glu2014Lys p.Asp2708Asn | missense missense |
3 5 |
reduced (reduced) | NA [31] |
ATM (NM_000051.4) variants including American College of Medical Genetics (ACMG) criteria classification. ATM protein expression was assessed in vitro. A-T, ataxia telangiectasia; ATM, A-T mutated.